Provided by Tiger Trade Technology Pte. Ltd.

PROCEPT BioRobotics

17.72
-0.1900-1.06%
Volume:337.80K
Turnover:5.98M
Market Cap:1.01B
PE:-9.10
High:17.88
Open:17.80
Low:17.52
Close:17.91
52wk High:38.11
52wk Low:16.67
Shares:57.27M
Float Shares:54.47M
Volume Ratio:0.34
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9478
EPS(LYR):-1.7207
ROE:-30.24%
ROA:-14.75%
PB:2.98
PE(LYR):-10.30

Loading ...

Evercore ISI Initiates Coverage on PROCEPT BioRobotics With Outperform Rating, $30 Price Target

MT Newswires Live
·
Jun 24

Procept Biorobotics Initiated at Outperform by Evercore ISI Group

Dow Jones
·
Jun 24

Procept BioRobotics initiated with an Outperform at Evercore ISI

TIPRANKS
·
Jun 24

Procept Biorobotics Corp : Evercore Isi Initiates Coverage with Outperform Rating; Price Target $30

THOMSON REUTERS
·
Jun 24

Analysts’ Top Healthcare Picks: PROCEPT BioRobotics (PRCT), Prime Medicine, Inc. (PRME)

TIPRANKS
·
Jun 23

PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed?

Simply Wall St.
·
Jun 23

PROCEPT BioRobotics (PRCT) Stock Could Be 14% Undervalued After Growth Outlook Holds

Simply Wall St.
·
Jun 20

PROCEPT BioRobotics Shares Drop After Downgrade From Leerink Partners

MT Newswires Live
·
Jun 12

PROCEPT BioRobotics Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
Jun 11

Leerink Partners Downgrades PROCEPT BioRobotics to Market Perform From Outperform, Adjusts PT to $29 From $31

MT Newswires Live
·
Jun 11

Procept Biorobotics Corp : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $29 From $31

THOMSON REUTERS
·
Jun 11

Procept BioRobotics downgraded to Market Perform from Outperform at Leerink

TIPRANKS
·
Jun 11

Top PROCEPT BioRobotics Executive Makes Notable Stock Move

TIPRANKS
·
Jun 11

PROCEPT BioRobotics Shareholders Back Board, Pay and Auditor

TIPRANKS
·
Jun 11

Procept BioRobotics shareholders elect directors at annual meeting

Reuters
·
Jun 11

PROCEPT BioRobotics (PRCT) Is Up 5.7% After New WATER IV Trials Expand Aquablation Testing Scope

Simply Wall St.
·
Jun 08

PROCEPT BioRobotics (PRCT) Receives a Buy from TD Cowen

TIPRANKS
·
Jun 01

Procept Biorobotics® Advances Prostate Cancer Program With Water Iv Study Enrollment Completion and Expanded Ide Approval

THOMSON REUTERS
·
May 28

PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

GlobeNewswire
·
May 28

A Look At PROCEPT BioRobotics (PRCT) Valuation After Its Better Than Expected Q1 Earnings And Analyst Updates

Simply Wall St.
·
May 27